ArticlePulmonary therapy2022

Assessment of Patient Perspectives and Barriers to Self-Infusion of Augmentation Therapy for Alpha-1 Antitrypsin Deficiency During the COVID-19 Pandemic.

Jacob Colello et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.